Finance

Lists
003000:KRX
Bukwang Pharm Co Ltd
3 915,00 KRW
-0,76%
(-30,00) 1D
20-окт., 11:13:31 GMT+9  ·   KRW
All symbols
SymbolPriceChange% Change
Generating top insights for 003000...
Open
3 905 KRW
High
3 995 KRW
Low
3 875 KRW
Mkt. cap
386,27 млд
Avg. vol.
422,60 миң
Volume
88,50 миң
Dividend
3,19%
Quarterly dividend
31 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
42,38
52-wk high
9 890 KRW
52-wk low
3 510 KRW
EPS
92 KRW
Shares outstanding
98,66 млн
No. of employees
630
Open
3 905 KRW
High
3 995 KRW
Low
3 875 KRW
Mkt. cap
386,27 млд
Avg. vol.
422,60 миң
Volume
88,50 миң
Dividend
3,19%
Quarterly dividend
31 KRW
Ex-dividend date
2025-ж., 29-дек.
P/E ratio
42,38
52-wk high
9 890 KRW
52-wk low
3 510 KRW
EPS
92 KRW
Shares outstanding
98,66 млн
No. of employees
630
News stories
From web sources and news partners
About Bukwang Pharm Co Ltd
CEOKim Sang-hun | Hui Won Yoo
Employees630
Founded1960
Headquarters-
SectorPharmaceutical industry
Previous reportsAll values in KRW
Loading Previous Earnings...
Revenue
Net income
All values in KRW
2025-ж. сен.
2025-ж. дек.
2026-ж. мар.
2026-ж. июн.
Revenue
47,81 млд
62,51 млд
47,78 млд
56,99 млд
Cost of goods sold
28,36 млд
29,86 млд
28,91 млд
32,59 млд
Cost of revenue
28,36 млд
29,86 млд
28,91 млд
32,59 млд
Research and development expenses
4,24 млд
6,31 млд
4,56 млд
7,08 млд
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
14,23 млд
17,02 млд
11,50 млд
15,91 млд
Operating expense
18,47 млд
24,50 млд
17,76 млд
22,99 млд
Total operating expenses
46,84 млд
54,36 млд
46,67 млд
55,58 млд
Operating income
979,05 млн
8,16 млд
1,10 млд
1,41 млд
Other non operating income
244,96 млн
3,01 млд
981,71 млн
449,24 млн
EBT including unusual items
1,22 млд
2,99 млд
2,09 млд
1,84 млд
EBT excluding unusual items
1,22 млд
11,56 млд
2,09 млд
1,84 млд
Income tax expense
-272,07 млн
-1,67 млд
924,48 млн
447,55 млн
Effective tax rate
-22,24%
-55,87%
44,32%
24,37%
Other operating expenses
-
628,87 млн
546,78 млн
-
Net income
1,53 млд
4,67 млд
1,18 млд
1,40 млд
Net profit margin
3,20%
7,47%
2,46%
2,46%
Earnings per share
-
-
-
-
Interest and investment income
-
4,71 млд
-
-
Interest expense
-
-3,90 млд
-
-
Net interest expenses
-
815,55 млн
-
-
Depreciation and amortization charges
-
350,64 млн
642,06 млн
-
EBITDA
2,40 млд
9,70 млд
2,48 млд
2,48 млд
Gain or loss from assets sale
-299,00 миң
-12,46 млн
-
-49,19 млн
AI content may include mistakes. Learn more
Google колдонмолору